206 IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY
Campelo, M. Díez, Caballero, J.C., Barba, M. Sánchez, Del Rey, M., Janusz, K., Lumbreras, E., Abáigar, M., Robledo, C., Jerez, A., Calderón-Cabrera, C., Such, E., Cervera, J., Sanz, G., Valcárcel, D.,Volume:
39
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/S0145-2126(15)30207-1
Date:
April, 2015
File:
PDF, 170 KB
english, 2015